Class II · Moderate riskOngoing Initiated Mar 17, 2026 (6 months ago)
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
What was recalled
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9262-08.
Recalling firm
Teva Pharmaceuticals USA, Inc
NDC code
0480-9262-08
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0406-2026
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Teva Pharmaceuticals USA, IncNDC 0480-9259-08D-0405-2026
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Teva Pharmaceuticals USA, IncNDC 0480-9257-08D-0404-2026